AML Patients Bearing FLT3 Mutations Based on Peripheral Blast Clearance

Clinical trial NCT04174612 · UNKNOWN

Trial details

NCT number: NCT04174612
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia With FLT3/ITD Mutation

Start date: 2020-04-24
Primary completion: 2022-12-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.